4//SEC Filing
Smith Karen L. 4
Accession 0001842952-24-000079
CIK 0001842952other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 8:15 AM ET
Size
5.5 KB
Accession
0001842952-24-000079
Insider Transaction Report
Form 4
Smith Karen L.
Director
Transactions
- Award
Stock Option (right to buy)
2024-09-04+19,315→ 19,315 totalExercise: $2.43Exp: 2034-09-03→ Common Stock (19,315 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001639637
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 8:15 AM ET
- Size
- 5.5 KB